London, Oct. 09, 2019 (GLOBE NEWSWIRE) — According to a new market research report  by Type (Consumables, NGS Platform, Software), Sequencing Type (Whole Genome, Targeted), Technology (Sequencing by Synthesis, Sequencing by Ligation), Application (Clinical, Research), End User – Global Forecasts to 2025, published by Meticulous Research®, the global next-generation sequencing (NGS) market is expected to grow at a CAGR of 16.2% from 2019 to reach $10.35 billion by 2025.

Next Generation Sequencing (NGS) is a combination of technologies that are used to determine the sequence of nucleotides in a given DNA sample. These technologies enable sequencing of DNA or RNA in a shorter time as compared to Sanger sequencing technology, which is limited to sequencing short DNA pairs and produce low quality results. The technological advancements in sequencing procedures, surge in genome mapping programs, and increase in NGS technology-based drug discovery platforms are some of the key factors driving a steady growth in the global next-generation sequencing (NGS) market.

Request Sample Report: 

In recent years, the cost of sequencing has declined exponentially. This has boosted the number of genome related projects, and has led to a greater adoption of NGS technologies across the globe. According to National Genome Research Institute, the cost per genome sequencing was $100 million in 2001, which reduced to $800,000 in 2008, which further reduced to ~$1,200 in 2019. As a result, genomics is widely being used to deliver advances in disease detection and therapeutics. This plummeting cost of sequencing has enabled governments to use genomic analysis as a major part of disease diagnosis and in development of personalized medicine. For instance, according to the National Cancer Institute (U.S.), in the U.S. Cancer Moonshot initiative was launched in 2016 aimed to accelerate cancer research, prevention, and screening.

The next-generation sequencing market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2025– by product type, sequencing type, technology, application, end user, and geography. The study also evaluates industry competitors and analyzes their market share at global and regional level.

Based on product type, the overall next-generation sequencing market is segmented into consumables, NGS platforms/instruments, software, and services. In 2019, the consumables segment is estimated to account for the largest share of the overall next-generation sequencing market and is slated to grow at the fastest CAGR during the forecast period. The large share of this segment is mainly attributed to growing number of sequencing procedures being performed globally and recurrent use of consumables in the sequencing procedures.

Based on sequencing type, the overall next-generation sequencing market is categorized into Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), Targeted Sequencing, and others. The targeted sequencing segment is expected to account for the largest share of the overall NGS market in 2019. The large share of this segment is mainly attributed to higher sensitivity of technique to call variants, low sequencing costs as compared to other sequencing technologies, and generation of manageable data volumes with reliable results.

On the basis of technology, the overall NGS market is segmented into Sequencing by Synthesis (SBS), Ion-Semiconductor Sequencing, Single Molecule Real Time (SMRT), Sequencing by Ligation (SBL), Nanopore sequencing, and others. In 2019, Sequencing by Synthesis segment is expected to account for the largest share of the overall next-generation sequencing market, and is slated to grow at the fastest CAGR during the forecast period. High accuracy in DNA sequencing by SBS, highest yield of error free throughput, and growing incorporation of this technology in NGS products have led to a greater share of SBS technology in the next-generation sequencing market.

The global next-generation sequencing market is further categorized on the basis of application areas, such as, clinical (oncology, reproductive health diagnostics, cardiovascular) and research (drug discovery, agriculture & animal research). The clinical applications segment is estimated to account for the largest share of the overall NGS market in 2019, and it is forecasted to grow at the fastest CAGR during the forecast period. The large share of this segment is mainly attributed to rising incidence of cancer, growing prevalence of genetic disorders in infants, and use of NGS technology in diagnostic procedures to make better clinical decisions.

Meticulous Research® is Glad to Announce Year-End Discount Offer.
Grab Maximum 25% Discount On All Our , Discount Valid Till 31st December 2019

Based on end user, the overall NGS market is sub-segmented into clinical diagnostic laboratories, pharmaceutical & biotechnology companies, academic & research institutes, and others. The clinical diagnostic laboratories segment is estimated to account for the largest share of the overall next generation sequencing market in 2019, and is forecasted to grow at the fastest CAGR during the forecast period. This is primarily attributed to increasing volume of diagnostic procedures performed in the clinical diagnostic laboratories, growing number of samples outsourced by academic & research laboratories and hospitals & clinics to clinical diagnostic laboratories, growing adoption of advanced next-generation sequencing products, and increasing adoption of genetic analysis in the clinical diagnosis to provide tailored treatments for patients.

The report also includes extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The next-generation sequencing market has witnessed a number of product launches in recent years. For instance, in April 2019, Pacific Biosciences of California Inc.  launched Sequel II System with SMRT Cell 8M, instrument control software, and the SMRT Link software package to reduce sequencing project costs and timelines as compared to the previous Sequel system. Similarly, in January 2018, Illumina, Inc. (U.S.) launched iSeq 100 sequencing system, which offers exceptional data accuracy, at a low capital cost.

The global next-generation sequencing market is highly consolidated market with major players, such as, Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Qiagen N.V. (Netherlands), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), 10X Genomics, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies Ltd (U.K.), Beckman Coulter, Inc. (U.S.), GenapSys, Inc. (U.S.), New England Biolabs, Inc. (U.S.), PierianDx (U.S.), and BGI Genomics (China) operating effectively in the global market.

Browse key industry insights spread across 253 pages with 328 market data tables & 51 figures & charts from the report: 

Scope of the Report:

Next-Generation Sequencing Market, by Type

Next-Generation Sequencing Market, by Sequencing Type

Next-Generation Sequencing Market, by Technology

Next-Generation Sequencing Market, by Application

Next-Generation Sequencing Market, by End User

Next-Generation Sequencing Market, by Geography

Download Free Sample Report Now @ 

Related Reports-
 by Service Type (Targeted Sequencing, Exome, RNA-Seq, ChIP Sequencing), Technology (Sequencing by Synthesis, Nanopore, SMRT), Application (Clinical Diagnosis, Biomarker Discovery), and End User – Global Forecast to 2025

 (NGS Informatics Market) Size by Product and Services, by Function, by Application, by End – Global Forecast to 2022

About Meticulous Research®

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Mr. Khushal Bombe Meticulous Research® Direct Lines: + (North America) + (Europe) + (Asia-Pacific) Email- sales Visit Our Website: https://www.meticulousresearch/ Meticulous Research® Blog: Connect with us on LinkedIn- https://www.linkedin/company/meticulous-research